Extrait

This will be an international, multi-center, post-marketing surveillance study in patients with moderate renal insufficiency who are administered gadodiamide, Omniscan, during a MRI. Omniscan will be administered intravenously at the medical discretion of the prescribing physician.

Critère d'inclusion

• chronic kidney disease ,Renal Insufficiency

Liens

• ictrp
• nct